Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09WFL
|
|||
| Former ID |
DIB009112
|
|||
| Drug Name |
MP-12
|
|||
| Synonyms |
Rift Valley fever vaccine, USAMRIID; ZH548-M12; TSI-GSD-223
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Rift valley fever [ICD-11: 1D44; ICD-10: A92.4] | Phase 2 | [1] | |
| Company |
US Army Medical Research Institute of Infectious Diseases
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H15NO3
|
|||
| Canonical SMILES |
CC1=C(C(=CC=C1)C)NC(=O)C2=CC=CC=C2C(=O)O
|
|||
| InChI |
1S/C16H15NO3/c1-10-6-5-7-11(2)14(10)17-15(18)12-8-3-4-9-13(12)16(19)20/h3-9H,1-2H3,(H,17,18)(H,19,20)
|
|||
| InChIKey |
LLECMGGNFBKPRH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 19368-18-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00415051) Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.